BookRichard W. Compans, Walter A. Orenstein, editors.
Contents:
Part I. Pandemic Influenza Overview
Pandemic influenza as a current threat
Antigenic cross-reactivity among H5N1 Viruses
-- Part II. Current Approaches for Human and Avian Vaccine Production
Seasonal influenza vaccines
Generation and characterization of candidate vaccine viruses for pre-pandemic influenza vaccines
Live attenuated vaccines for pandemic influenza
Influenza vaccines for avian species
Development and application of avian influenza vaccines in China
-- Part III. Novel Vaccine Approaches
Designing vaccines for pandemic influenza
Attenuated influenza virus vaccines with modified NS1 proteins
DNA Vaccines against Influenza viruses
Recombinant proteins produced in insect cells
Influenza neuraminidase as a vaccine antigen
Recombinant vectors as influenza vaccines
Influenza virus-like particles as pandemic vaccines
Pandemic influenza vaccines
Adjuvants for pandemic influenza vaccines
-- Part IV. Novel Approaches of Vaccine Delivery
Transcutaneous immunization with influenza vaccines
Microneedle-based vaccines
-- Part V. Vaccine Evaluation, Production and Distribution
Animal models for evaluation of influenza vaccines
Immunosenescence and influenza vaccine efficacy
Vaccines for pandemic influenza: summary of recent clinical trials
Considerations for licensure of influenza vaccines with pandemic and pre-pandemic indications
Strategies for broad global access to pandemic influenza
Prioritization of pandemic influenza vaccine: rationale and strategy for decision-making.
Location
Version
Call Number
Items